News Releases
Viewing Category: Chronic hepatitis B
-
MONTREAL, CANADA — February 8, 2007
Quebec is the first province in Canada to reimburse new drug developed to treat chronic hepatitis B
Categories: Baraclude | Chronic hepatitis B
-
MONTREAL, CANADA — September 20, 2006.
Newly approved Baraclude™ reduces virus to undetectable levels in chronic hepatitis B patients
Baraclude Significantly Superior to Lamivudine
Categories: Baraclude | Chronic hepatitis B
